Free Trial

Ekso Bionics (EKSO) Short Interest Ratio & Short Volume

Ekso Bionics logo
$0.47 -0.02 (-4.22%)
As of 04:00 PM Eastern

Ekso Bionics Short Interest Data

Ekso Bionics (EKSO) has a short interest of 436,300 shares, representing 2.11% of the float (the number of shares available for trading by the public). This marks a -32.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 897,594 shares to cover all short positions.

Current Short Interest
436,300 shares
Previous Short Interest
646,100 shares
Change Vs. Previous Month
-32.47%
Dollar Volume Sold Short
$173,254.73
Short Interest Ratio
2.0 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
29,018,000 shares
Short Percent of Float
2.11%
Today's Trading Volume
142,191 shares
Average Trading Volume
897,594 shares
Today's Volume Vs. Average
16%
Short Selling Ekso Bionics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Ekso Bionics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EKSO Short Interest Over Time

EKSO Days to Cover Over Time

EKSO Percentage of Float Shorted Over Time

Ekso Bionics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025436,300 shares $173,254.73 -32.5%2.1%2 $0.40
3/31/2025646,100 shares $260,378.30 -16.6%3.1%0.6 $0.40
3/15/2025774,400 shares $328,268.16 -13.7%3.7%0.7 $0.42
2/28/2025897,700 shares $471,112.96 -5.2%4.3%0.8 $0.52
2/15/2025947,300 shares $540,245.19 -15.4%4.6%0.9 $0.57
1/31/20251,120,000 shares $603,008.00 -23.8%N/A1.1 $0.54
1/15/20251,470,000 shares $955,647.00 +511.7%N/A1.5 $0.65
12/31/2024240,300 shares $146,583.00 +92.9%N/A0.3 $0.61
12/15/2024124,600 shares $70,610.82 +2.6%N/A1.3 $0.57
11/30/2024121,500 shares $84,442.50 +40.0%N/A1.5 $0.70
11/15/202486,800 shares $65,100.00 +17.6%N/A1.1 $0.75
10/31/202473,800 shares $63,172.80 -47.8%N/A0.9 $0.86
10/15/2024141,400 shares $149,884.00 -28.0%N/A1.6 $1.06
9/30/2024196,300 shares $227,708.00 +1.4%N/A2.2 $1.16
9/15/2024193,600 shares $237,160.00 -46.4%N/A2.2 $1.23
8/31/2024360,900 shares $433,080.00 +393.7%N/A4.3 $1.20
8/15/202473,100 shares $65,095.55 +52.0%N/A0.9 $0.89
7/31/202448,100 shares $50,505.00 -57.2%N/A0.7 $1.05
7/15/2024112,500 shares $154,125.00 -19.4%N/A2.1 $1.37
6/30/2024139,500 shares $147,172.50 +65.9%N/A2.2 $1.06
6/15/202484,100 shares $88,725.50 -28.4%N/A1.2 $1.06
5/31/2024117,500 shares $135,125.00 -27.7%N/A1.5 $1.15
5/15/2024162,600 shares $221,136.00 -26.9%N/A1.2 $1.36
4/30/2024222,300 shares $275,652.00 +16.8%N/A1.6 $1.24
4/15/2024190,300 shares $274,032.00 +41.7%N/A1.1 $1.44
3/31/2024134,300 shares $182,648.00 +20.8%N/A0.7 $1.36
3/15/2024111,200 shares $146,784.00 -23.4%N/A0.5 $1.32
2/29/2024145,100 shares $275,690.00 -15.7%N/A0.7 $1.90
2/15/2024172,100 shares $351,084.00 -32.0%N/A1 $2.04
1/31/2024253,000 shares $579,370.00 -32.2%N/A1.4 $2.29
1/15/2024373,300 shares $623,411.00 +44.8%N/A2.3 $1.67
12/31/2023257,900 shares $644,750.00 -13.9%2.2%2.1 $2.50
12/15/2023299,600 shares $401,464.00 +206.0%2.6%3.5 $1.34
11/30/202397,900 shares $171,325.00 +37.7%0.8%1.3 $1.75
11/15/202371,100 shares $98,829.00 +109.7%0.6%1 $1.39
10/31/202333,900 shares $36,951.00 -2.3%0.3%0.5 $1.09
10/15/202334,700 shares $26,996.60 -13.7%0.3%0.7 $0.78
9/30/202340,200 shares $29,466.60 -45.8%0.4%0.8 $0.73
9/15/202374,200 shares $53,898.88 +105.5%0.7%1.5 $0.73
8/31/202336,100 shares $32,500.83 +32.7%0.3%0.7 $0.90
You’re About to Lose Everything – Act Now or Regret It Forever (Ad)

What If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands of tons of gold locked away in Fort Knox. But there hasn't been an independent audit in over 50 years—and now, both Elon Musk and former Congressman Ron Paul are demanding answers.

Request your FREE Wealth Protection Kit now to secure your future before the truth comes out.
8/15/202327,200 shares $29,648.00 -14.5%0.2%0.6 $1.09
7/31/202331,800 shares $36,888.00 -10.4%0.3%0.9 $1.16
7/15/202335,500 shares $42,955.00 -28.7%0.3%1.3 $1.21
6/30/202349,800 shares $71,214.00 +45.6%0.4%1.9 $1.43
6/15/202334,200 shares $46,512.00 -2.3%0.3%1.3 $1.36
5/31/202335,000 shares $47,250.00 -4.1%0.3%1.4 $1.35
5/15/202336,500 shares $59,860.00 +9.6%0.3%1.6 $1.64
4/30/202333,300 shares $49,617.00 -19.2%0.3%1.4 $1.49
4/15/202341,200 shares $64,684.00 +5.4%0.4%1.7 $1.57
3/31/202339,100 shares $64,515.00 -20.4%0.3%1.2 $1.65
3/15/202349,100 shares $69,722.00 +1.9%0.4%1.5 $1.42
2/28/202348,200 shares $68,926.00 -3.6%0.4%1.1 $1.43
2/15/202350,000 shares $85,900.00 -0.4%0.4%1 $1.72
1/31/202350,200 shares $84,838.00 -26.8%0.5%1 $1.69
1/15/202368,600 shares $121,422.00 +36.4%0.6%1.3 $1.77
12/30/202250,300 shares $59,857.00 -41.8%0.5%1 $1.19
12/15/202286,400 shares $120,096.00 +100.0%0.8%1.9 $1.39
11/30/202243,200 shares $44,928.00 -11.8%0.4%1.1 $1.04
11/15/202249,000 shares $63,700.00 -20.3%0.4%1.6 $1.30
10/31/202261,500 shares $101,475.00 -18.4%0.5%1.7 $1.65
10/15/202275,400 shares $107,068.00 -11.3%0.7%1.9 $1.42
9/30/202285,000 shares $132,600.00 -10.7%0.7%2.2 $1.56
9/15/202295,200 shares $205,632.00 +2.7%0.8%2 $2.16
8/31/202292,700 shares $217,845.00 +27.0%0.8%0.2 $2.35
8/15/202273,000 shares $181,770.00 -43.6%0.6%0.1 $2.49
7/31/2022129,400 shares $227,744.00 -4.3%1.1%0.2 $1.76
7/15/2022135,200 shares $229,569.60 -7.4%1.2%0.2 $1.70
6/30/2022146,000 shares $240,900.00 -77.7%1.3%0.3 $1.65
6/15/2022655,700 shares $1.23 million +1,322.3%5.6%1.2 $1.88
5/31/202246,100 shares $87,590.00 -20.5%0.4%1.1 $1.90
5/15/202258,000 shares $101,494.20 -11.3%0.5%1.3 $1.75
4/30/202265,400 shares $148,458.00 -15.5%0.6%1.5 $2.27
4/15/202277,400 shares $208,980.00 +14.8%0.7%1.8 $2.70
3/31/202267,400 shares $194,786.00 -3.3%N/A1.4 $2.89
3/15/202269,700 shares $179,826.00 +1.2%0.6%1.1 $2.58
2/28/202268,900 shares $179,140.00 -7.8%0.6%0.9 $2.60
2/15/202274,700 shares $194,220.00 -28.5%0.6%0.9 $2.60
1/31/2022104,400 shares $252,648.00 -11.1%0.8%1.1 $2.42
1/15/2022117,400 shares $297,022.00 +8.1%N/A1 $2.53
12/31/2021108,600 shares $287,790.00 -26.2%0.9%0.9 $2.65
12/15/2021147,100 shares $436,887.00 -11.0%1.2%1.4 $2.97
11/30/2021165,300 shares $537,225.00 -15.1%1.3%1.3 $3.25
11/15/2021194,800 shares $748,032.00 -3.6%1.6%1.6 $3.84
10/29/2021202,000 shares $812,040.00 +42.8%1.6%1.7 $4.02
10/15/2021141,500 shares $582,980.00 +9.7%1.1%1.4 $4.12
9/30/2021129,000 shares $595,980.00 -21.3%1.0%1.3 $4.62
9/15/2021164,000 shares $675,680.00 -8.6%1.3%1.6 $4.12
8/31/2021179,500 shares $858,010.00 -21.9%1.5%2.1 $4.78
8/13/2021229,800 shares $1.10 million -15.8%1.9%2.3 $4.79
7/30/2021272,900 shares $1.33 million +34.9%2.2%1.7 $4.86
You’re About to Lose Everything – Act Now or Regret It Forever (Ad)

What If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands of tons of gold locked away in Fort Knox. But there hasn't been an independent audit in over 50 years—and now, both Elon Musk and former Congressman Ron Paul are demanding answers.

Request your FREE Wealth Protection Kit now to secure your future before the truth comes out.
7/15/2021202,300 shares $942,718.00 -4.9%1.6%1.1 $4.66
6/30/2021212,800 shares $1.17 million +33.2%1.7%0.9 $5.50
6/15/2021159,800 shares $872,508.00 -40.7%1.3%0.5 $5.46
5/28/2021269,500 shares $1.53 million -30.8%2.2%0.8 $5.68
5/14/2021389,300 shares $1.95 million -0.1%3.2%1.1 $5.02
4/30/2021389,800 shares $2.00 million +36.2%3.2%0.7 $5.12
4/15/2021286,200 shares $1.85 million +67.4%N/A0 $6.48
3/31/2021171,000 shares $1.01 million -5.9%1.5%0.3 $5.90
3/15/2021181,800 shares $1.33 million -5.7%1.6%0.4 $7.30
2/26/2021192,800 shares $1.38 million -6.3%1.7%0.5 $7.16
2/12/2021205,700 shares $1.98 million -1.5%1.9%0.6 $9.61
1/29/2021208,800 shares $1.94 million -15.5%2.8%0.8 $9.30
1/15/2021247,000 shares $1.99 million +31.4%3.3%1.5 $8.04
12/31/2020188,000 shares $1.17 million +28.9%2.5%1.4 $6.22
12/15/2020145,900 shares $752,844.00 -16.9%2.0%1.4 $5.16
11/30/2020175,500 shares $1.00 million +7.1%2.4%2 $5.72
11/15/2020163,800 shares $753,480.00 -11.0%2.2%1.6 $4.60
10/30/2020184,000 shares $769,120.00 +7.7%2.5%1.8 $4.18
10/15/2020170,800 shares $845,460.00 -12.7%2.3%1.2 $4.95
9/30/2020195,700 shares $929,575.00 -3.9%2.7%0.8 $4.75
9/15/2020203,700 shares $1.08 million -15.2%2.8%0.1 $5.31
8/31/2020240,100 shares $1.19 million -24.8%3.3%0.1 $4.94
8/14/2020319,100 shares $1.87 million -11.0%4.3%0.1 $5.87
7/31/2020358,700 shares $2.34 million -34.3%4.9%0.1 $6.52
7/15/2020546,200 shares $4.28 million -76.6%7.9%0.2 $7.83
6/30/20202,330,000 shares $16.57 million +692.0%36.0%0.8 $7.11
6/15/2020294,200 shares $1.11 million +20.6%4.5%1.3 $3.78
5/29/2020244,000 shares $861,320.00 -4.6%4.7%1.6 $3.53
5/15/2020255,800 shares $767,400.00 -18.9%4.9%2.5 $3.00
4/30/2020315,200 shares $1.23 million +0.4%6.1%3.6 $3.89

EKSO Short Interest - Frequently Asked Questions

What is Ekso Bionics' current short interest?

Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 436,300 shares of EKSO short. 2.11% of Ekso Bionics' shares are currently sold short. Learn More on Ekso Bionics' current short interest.

What is a good short interest ratio for Ekso Bionics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EKSO shares currently have a short interest ratio of 2.0. Learn More on Ekso Bionics's short interest ratio.

Which institutional investors are shorting Ekso Bionics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ekso Bionics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ekso Bionics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.11% of Ekso Bionics' floating shares are currently sold short.

Is Ekso Bionics' short interest increasing or decreasing?

Ekso Bionics saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 436,300 shares, a decrease of 32.5% from the previous total of 646,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ekso Bionics' short interest compare to its competitors?

2.11% of Ekso Bionics' shares are currently sold short. Here is how the short interest of companies in the industry of "machinery" compare to Ekso Bionics: Amtech Systems, Inc. (0.64%), Westport Fuel Systems Inc. (4.16%), TPI Composites, Inc. (23.75%), Nauticus Robotics, Inc. (9.35%), SCHMID Group (0.86%), Fuel Tech, Inc. (0.37%), Tungray Technologies Inc. (1.66%), Greenland Technologies Holding Co. (3.39%), CVD Equipment Co. (0.39%), ZOOZ Power Ltd. (0.80%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Ekso Bionics stock?

Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ekso Bionics?

A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further.

How often is Ekso Bionics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:EKSO) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners